- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Duplex ultrasonography.
Displaying page 1 of 1.
EudraCT Number: 2016-002911-16 | Sponsor Protocol Number: na | Start Date*: 2016-12-28 |
Sponsor Name:Maastricht University Medical Center | ||
Full Title: PET/MRI and plaque vulnerability A feasibility study of 18F-Flutemetamol in atherosclerosis | ||
Medical condition: Atherosclerosis in the carotids and coronary arteries. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2004-003703-21 | Sponsor Protocol Number: 5802003 | Start Date*: 2005-01-28 |
Sponsor Name:Semmelweis University | ||
Full Title: The role of hyperhomocysteinemia in the genesis of atherothrombotic vascular disease | ||
Medical condition: Established cardiovascular disease with elevated levels of homocystein | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005731-16 | Sponsor Protocol Number: TG-M-005 | Start Date*: 2007-01-05 |
Sponsor Name:ThromboGenics Ltd. | ||
Full Title: An Open Label Clinical Trial of Microplasmin Administered via the Trellis-8 Infusion System for the Treatment of Acute Iliofemoral Deep Vein Thrombosis | ||
Medical condition: Acute Iliofemoral Deep Vein Thrombosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-000449-15 | Sponsor Protocol Number: DIONYSIUS | Start Date*: 2020-12-11 |
Sponsor Name:Amsterdam University Medical Centers, location AMC | ||
Full Title: Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently? | ||
Medical condition: Ischemic diabetic foot ulcers | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001001-40 | Sponsor Protocol Number: DT-DP-UC-CR-01 | Start Date*: 2014-06-13 |
Sponsor Name:DermaTools Biotech GmbH | ||
Full Title: A multicentre, double-blind, randomised, controlled phase II/III study to evaluate the efficacy and safety of the new wound healing solution Diperoxochloric acid (DPOCl, DermaPro®) in patients with... | ||
Medical condition: Venous leg ulcer (ulcus cruris) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LV (Prematurely Ended) LT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-003009-88 | Sponsor Protocol Number: DU176b-E-U210 | Start Date*: 2012-12-27 | |||||||||||
Sponsor Name:Daiichi Sankyo Development Ltd | |||||||||||||
Full Title: A RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP, MULTI-CENTER STUDY OF ADDING EDOXABAN OR CLOPIDOGREL TO ASPIRIN TO MAINTAIN PATENCY IN SUBJECTS WITH PERIPHERAL ARTERIAL DISEASE FOLLOWING FEMOROPOPLIT... | |||||||||||||
Medical condition: Edoxaban is being investigated for use in PAD subjects after femoropopliteal endovascular interventions with/without stent placement for the maintenance of patency and prevention of re-intervention. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) NL (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003762-18 | Sponsor Protocol Number: 2007.468/11 | Start Date*: 2008-10-23 | |||||||||||
Sponsor Name:Hospices Civils de Lyon | |||||||||||||
Full Title: Prospective monocenter accuracy study of Vasovist contrast enhanced magnetic resonance venography (CE-MRV) to detect venous thrombi in patients with Ultrasonography detected peripheral acute deep ... | |||||||||||||
Medical condition: Acute deep vein thrombosis (DVT) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002311-64 | Sponsor Protocol Number: SuloPrima | Start Date*: 2021-10-01 | |||||||||||
Sponsor Name:ALFASIGMA CZECH s.r.o. | |||||||||||||
Full Title: Efficacy and safety of sulodexide in the treatment of chronic primary venous disease of the lower extremities: randomized double-blind placebo-controlled clinical trial | |||||||||||||
Medical condition: Chronic primary venous disease of the lower limbs | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
